Nonprimed and DYRK1A-primed GSK3 beta-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons. - Wikidata - awgldk - TriplyDB

Nonprimed and DYRK1A-primed GSK3 beta-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons.

Nonprimed and DYRK1A-primed GSK3 beta-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons.

http://www.wikidata.org/entity/Q43102409

about

DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome GSK-3: Functional Insights from Cell Biology and Animal Models.Neuronal deletion of GSK3β increases microtubule speed in the growth cone and enhances axon regeneration via CRMP-2 and independently of MAP1B and CLASP2.Tumor suppressor DYRK1A effects on proliferation and chemoresistance of AML cells by downregulating c-Myc.Phosphorylation by Dyrk1A of clathrin coated vesicle-associated proteins: identification of the substrate proteins and the effects of phosphorylation.SILAC-based quantitative proteomic analysis of human lung cell response to copper oxide nanoparticles.Nanomechanical property maps of breast cancer cells as determined by multiharmonic atomic force microscopy reveal Syk-dependent changes in microtubule stability mediated by MAP1B.Drebrin contains a cryptic F-actin-bundling activity regulated by Cdk5 phosphorylation.What Are the bona fide GSK3 Substrates?The role of microtubule-associated protein 1B in axonal growth and neuronal migration in the central nervous system.Modeling the functional genomics of autism using human neurons.DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3 Microtubule stability, Golgi organization, and transport flux require dystonin-a2-MAP1B interaction.Protein Kinase A Opposes the Phosphorylation-dependent Recruitment of Glycogen Synthase Kinase 3β to A-kinase Anchoring Protein 220 Specific serine-proline phosphorylation and glycogen synthase kinase 3β-directed subcellular targeting of stathmin 3/Sclip in neurons.Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A.Large scale phosphoproteome analysis of LNCaP human prostate cancer cells Usp14 deficiency increases tau phosphorylation without altering tau degradation or causing tau-dependent deficits.New Perspectives of Dyrk1A Role in Neurogenesis and Neuropathologic Features of Down Syndrome Intracellular distribution of differentially phosphorylated dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A).Activation, regulation, and inhibition of DYRK1A.MNB/DYRK1A as a multiple regulator of neuronal development.The MAP1B case: an old MAP that is new again.Importance of gene dosage in controlling dendritic arbor formation during development.Boosting CNS axon regeneration by harnessing antagonistic effects of GSK3 activity.RNA-binding proteins of the NXF (nuclear export factor) family and their connection with the cytoskeleton.Autism genetics - an overview.Dyrk kinases regulate phosphorylation of doublecortin, cytoskeletal organization, and neuronal morphology.Depletion of JMJD5 sensitizes tumor cells to microtubule-destabilizing agents by altering microtubule stability.Collapsin response mediator proteins (CRMPs) are a new class of microtubule-associated protein (MAP) that selectively interacts with assembled microtubules via a taxol-sensitive binding interaction.Sustained GSK3 activity markedly facilitates nerve regeneration.Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans.ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule-associated proteins.Autism-associated Dyrk1a truncation mutants impair neuronal dendritic and spine growth and interfere with postnatal cortical development.Collapsin response-mediator protein 5 (CRMP5) phosphorylation at threonine 516 regulates neurite outgrowth inhibition.Dyrk1A influences neuronal morphogenesis through regulation of cytoskeletal dynamics in mammalian cortical neurons.Evolution of the spatial distribution of MAP1B phosphorylation sites in vertebrate neurons.MAP1B mutations cause intellectual disability and extensive white matter deficit Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A

P2860

Q26745413-4BDFBD9F-FD90-4584-9333-3B3B0E27047C Q30472813-971EB534-BA7E-4DAA-AD35-8E14A2E4364F Q30597608-8F0CB69E-6034-4F2C-AB22-645ADA1F522F Q31164546-6810983F-D0A5-479C-9236-CFB2CFF1CA87 Q34238748-F652F8E8-8E86-4C26-9D40-63EF218F19E5 Q34627914-93799C1C-2CCD-49A5-B7A1-AB420B5EE1F8 Q34972279-4ECDDF41-4AE0-46B9-93F6-8FFA9789CD0F Q34974697-DC6884AF-2DD8-40D0-BA98-EDF46D90A43B Q35001234-06D53D28-3A1F-4AED-AB4A-0E1BFAAC7FCF Q35127376-1FF3CAF6-4561-4410-94A0-E885176B9CD1 Q35207317-9D5298B1-4BBA-4689-B909-64800CEC89F6 Q35640834-7C00F41D-4815-4994-9474-53A502868C37 Q35841751-B4D75309-DA28-48BF-A250-6DC8966FE996 Q35925772-A3E11B25-6B5F-499E-82F7-D4087B811E6E Q36052564-FC0B6F90-A847-4F12-B8C3-20D93440F749 Q36184569-7B120B72-EE58-4B4E-A59B-2DA656693E36 Q36207372-87529D3F-1C8D-4A82-A7D1-E571531BD83B Q36354014-29707789-EA73-4173-83E9-2FB1AC3CDD16 Q37500309-36F3FC1E-D37C-4272-84D0-3DC36568F443 Q37633160-10FD2339-A42E-44B5-92E8-AC007C0710F8 Q37815234-E72ECDD0-FB6A-4997-95A3-5DEF8C528F93 Q37820722-EAAA4148-F496-4F9F-A016-71C1F5092DBD Q38202088-84F193CF-5DB1-45EF-BDAF-3AF321EFB633 Q38537122-F4975DDC-CAD1-426F-A567-27E5E7DD914A Q38718341-E98910BB-2B59-4C87-AD4E-AC909A3060A8 Q38906415-7C2974D9-8082-4C45-90E8-FE9307BD18EA Q38981431-FF92DF94-6BD2-4400-9096-A55D62A9E3C5 Q39391713-73A74DE5-D901-4438-B174-7C2BA055B84F Q41817690-0B62FC12-7F41-4DB2-9461-0E69B478008A Q42575131-A5D7C5D6-A695-4635-937E-797A73B06E80 Q44773089-E619D2C1-B9CB-4E88-9337-83F9B6FA76B8 Q46157547-8E40D471-7CEA-4519-9FA4-1C0ACF719656 Q46180253-979107D5-F1EA-4B32-8194-552F712BF221 Q48321023-EE4194F1-EC1F-4CEA-8CC8-815FDEFFF2AE Q48650514-DF1071FD-873D-4E33-9543-EDBB90CC9448 Q48730272-FAE39BA5-DDDC-4A61-8662-25E894837EA2 Q51910121-7DA70F22-F9F9-4711-A3F1-A28D737F4F6A Q58701511-ABB8E797-D658-4D85-BBE7-9457F1778E09 Q59127645-9C6F90F9-ED13-4F9F-8CC4-93B633B72668

P2860

Nonprimed and DYRK1A-primed GSK3 beta-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons.

http://www.wikidata.org/entity/Q43102409

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Nonprimed and DYRK1A-primed GS ...... ule dynamics in growing axons.

@en

Nonprimed and DYRK1A-primed GS ...... ule dynamics in growing axons.

@nl

type

label

Nonprimed and DYRK1A-primed GS ...... ule dynamics in growing axons.

@en

Nonprimed and DYRK1A-primed GS ...... ule dynamics in growing axons.

@nl

prefLabel

Nonprimed and DYRK1A-primed GS ...... ule dynamics in growing axons.

@en

Nonprimed and DYRK1A-primed GS ...... ule dynamics in growing axons.

@nl

P1433

Q43102409-00A8A86C-6E90-4706-926F-36FFA9AD4855

P1476

Q43102409-2004128E-4289-43AC-8298-44CE51EB6336

P2093

Q43102409-4FB88E59-FCE9-4636-9485-C452E81CF4D6

Q43102409-8CC30A77-6628-411E-B04F-98E4EDB2F329

Q43102409-BF7597C9-A27E-453B-8491-8B8214FEEF16

P2860

Q43102409-02AD2EBA-8C4B-4F94-A78C-AD94E19EB6B7

Q43102409-0313B0EC-5E41-4581-A5D9-9AE174B4CE3D

Q43102409-073419B4-3B21-40C5-83FB-22CF2020D301

Q43102409-08F36A59-62D8-46CA-955A-7086BF0CC24A

Q43102409-0D5B0B7B-B075-436D-B12B-02A1E8AB7437

Q43102409-170BDED7-2D9B-49FF-A68E-F2130C2855C2

Q43102409-1D3A2D8F-6C83-437D-8D99-DE7D6744F55F

Q43102409-256A1D1A-BF05-460D-AF55-11E7F5B7D9A3

Q43102409-26FFCAF6-6C1A-44DC-BD63-825BBBDFB74C

Q43102409-2B1B2EEF-6680-4AD1-8994-894C1AC05CC3

P304

Q43102409-950B9655-B66B-4990-9C80-CB1D19FDC030

P31

Q43102409-589E1AA0-2515-4ABD-AA0C-318D7D76E244

P356

Q43102409-49763227-8071-4976-8178-C4D1646DFC5B

P407

Q43102409-54C13E00-708E-46E2-AC3C-7F2290B77D5E

P433

Q43102409-7D169390-CCA6-476C-BF08-036061B841E2

P478

Q43102409-2613B051-27FD-47E4-AC3F-5D72A6F2A193

P50

Q43102409-9D56E466-5FFD-4BF7-99A1-63AC0D3626D3

Q43102409-E9EA4ACD-DE2F-4D43-9CC9-A08C6A9E7C46

P577

Q43102409-5706EE49-B218-464A-A3E6-D9D5D05F1D68

P5875

Q43102409-957C002E-1F73-44AF-B10C-2BD601540F73

P698

Q43102409-A3A68FA6-4F99-4DAF-A4BB-F98974A18563

P921

Q43102409-022FD90B-3B80-4CD9-9B1E-93C4D1BB1206

P932

Q43102409-FEED433F-A37F-4AB3-ADC8-D6AB05EBDA1F

P356

P1433

Journal of Cell Science

P1476

Nonprimed and DYRK1A-primed GS ...... bule dynamics in growing axons

@en

P2093

Michaela Kraus

http://www.w3.org/2001/XMLSchema#string

Robert G Goold

http://www.w3.org/2001/XMLSchema#string

Timothy M E Scales

http://www.w3.org/2001/XMLSchema#string

P2860

The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase

Gigaxonin-controlled degradation of MAP1B light chain is critical to neuronal survival

GSK-3: tricks of the trade for a multi-tasking kinase

A molecular mechanism for the effect of lithium on development

Novel features of the light chain of microtubule-associated protein MAP1B: microtubule stabilization, self interaction, actin filament binding, and regulation by the heavy chain

Distinct priming kinases contribute to differential regulation of collapsin response mediator proteins by glycogen synthase kinase-3 in vivo

Human minibrain homologue (MNBH/DYRK1): characterization, alternative splicing, differential tissue expression, and overexpression in Down syndrome

JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins

Inhibition of GSK-3beta leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithium

MAP1B is encoded as a polyprotein that is processed to form a complex N-terminal microtubule-binding domain

P304

2424-2435

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1242/JCS.040162

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 14

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P50

Phillip R Gordon-Weeks

P577

2009-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26314146

http://www.w3.org/2001/XMLSchema#string

P698

19549690

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

P932

2704879

http://www.w3.org/2001/XMLSchema#string